...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review.
【24h】

Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review.

机译:放射治疗恶性胸腺瘤的肺部并发症剂量分析:回顾性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Radiation pneumonitis and fibrosis are limiting factors in radiation treatment (RT) of thoracic tumors. The objectives of this study were to quantify the influence of irradiated lung volume and dose on lung response, and to evaluate the influence of other prognostic factors.MATERIAL AND METHODS: Treatment histories of 55 thymoma patients were evaluated retrospectively for radiation pneumonitis and fibrosis. Complications were scored as pneumonitis if observed within 6 months of completion of RT, and as fibrosis if observed after 6 months. Complications were classified as 'all pneumonitis' and 'all fibrosis' if a patient either showed symptoms (such as chronic cough and dyspnea) or radiographic changes in lung. The second group scored as 'symptomatic pneumonitis' and 'symptomatic fibrosis' consisted of patients that exhibited clinical symptoms. Dose-volume data were estimated using representative anatomies combined with available individual dose data. The Lyman NTCP model was used to assess the dependence of lung complication incidence on dose and volume.RESULTS: The derived values of the parameters governing dose-volume dependence for symptomatic complications agreed with currently accepted and recently published values within the margins of error. Dose-response curves for complications that included radiographic changes were less steep than for symptomatic complications. The volume dependence for symptomatic fibrosis was more pronounced compared to all fibrosis. A strong correlation was observed between developing pneumonitis and developing fibrosis.CONCLUSIONS: The long survival allowed the assessment of lung complication data in thymoma patients for both acute and late response. Mean dose in lung strongly correlated with lung complications that manifest clinically. The determination of the dose-volume dependence is affected by the choice of endpoints (i.e. whether complications are scored based on clinical symptoms or radiographic changes not accompanied by clinical symptoms).
机译:背景与目的:辐射性肺炎和纤维化是胸腔肿瘤放射治疗(RT)的限制因素。这项研究的目的是量化辐照的肺体积和剂量对肺反应的影响,并评估其他预后因素的影响。材料与方法:回顾性评估55例胸腺瘤患者的治疗史,以评估其放射性肺炎和纤维化的发生。如果在RT完成后6个月内观察到并发症,则将其评分为肺炎,如果在6个月后观察到,则将其评分为纤维化。如果患者出现症状(例如慢性咳嗽和呼吸困难)或肺部影像学改变,则并发症可分为“所有肺炎”和“所有纤维化”。第二组为“症状性肺炎”和“症状性纤维化”,由表现出临床症状的患者组成。使用具有代表性的解剖结构并结合可用的单个剂量数据来估算剂量-体积数据。结果:用Lyman NTCP模型评估肺部并发症的发生率对剂量和体积的依赖性。结果:控制症状并发症剂量-体积依赖性的参数推导值与当前接受的和最近发表的误差范围内的值一致。包括影像学改变在内的并发症的剂量反应曲线比有症状的并发症要小。与所有纤维化相比,症状性纤维化的体积依赖性更为明显。结论:长生存期可以评估胸腺瘤患者急性和晚期反应的肺部并发症数据。肺中的平均剂量与临床表现出的肺部并发症密切相关。剂量-体积依赖性的确定受端点选择的影响(即是否根据临床症状或不伴随临床症状的影像学改变对并发症进行评分)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号